News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,077 Results
Type
Article (48008)
Company Profile (254)
Press Release (589815)
Section
Business (183684)
Career Advice (1821)
Deals (32144)
Drug Delivery (99)
Drug Development (73559)
Employer Resources (119)
FDA (15821)
Job Trends (14401)
News (313055)
Policy (30935)
Tag
Academia (2666)
Alliances (45070)
Alzheimer's disease (1203)
Approvals (15738)
Artificial intelligence (136)
Bankruptcy (281)
Best Places to Work (11398)
Biotechnology (188)
Breast cancer (110)
Cancer (963)
Cardiovascular disease (89)
Career advice (1548)
Cell therapy (213)
Clinical research (58358)
Collaboration (333)
Compensation (163)
COVID-19 (2369)
C-suite (88)
Data (922)
Diabetes (141)
Diagnostics (5834)
Drug pricing (95)
Earnings (70782)
Employer resources (108)
Events (100397)
Executive appointments (262)
FDA (16282)
Funding (287)
Gene therapy (164)
GLP-1 (626)
Government (4444)
Healthcare (19043)
Infectious disease (2448)
Inflammatory bowel disease (107)
Interviews (277)
IPO (14981)
Job creations (3357)
Job search strategy (1348)
Layoffs (386)
Legal (6963)
Lung cancer (161)
Manufacturing (145)
Medical device (13871)
Medtech (13875)
Mergers & acquisitions (17231)
Metabolic disorders (412)
Neuroscience (1444)
NextGen Class of 2024 (6463)
Non-profit (4464)
Northern California (1283)
Obesity (245)
Opinion (180)
People (54540)
Phase I (17775)
Phase II (25560)
Phase III (19755)
Pipeline (310)
Postmarket research (2457)
Preclinical (7287)
Radiopharmaceuticals (245)
Rare diseases (187)
Real estate (5244)
Regulatory (20748)
Research institute (2388)
Resumes & cover letters (285)
Southern California (1096)
Startups (3337)
United States (11907)
Vaccines (510)
Weight loss (202)
Date
Today (234)
Last 7 days (989)
Last 30 days (3160)
Last 365 days (34985)
2024 (30543)
2023 (39352)
2022 (50153)
2021 (54303)
2020 (52611)
2019 (46035)
2018 (34779)
2017 (31149)
2016 (30474)
2015 (35492)
2014 (27378)
2013 (23276)
2012 (24857)
2011 (25586)
2010 (24567)
Location
Africa (764)
Arizona (144)
Asia (37394)
Australia (6319)
California (2804)
Canada (1105)
China (204)
Colorado (129)
Connecticut (134)
Europe (83548)
Florida (388)
Georgia (103)
Illinois (321)
Indiana (195)
Kansas (83)
Maryland (556)
Massachusetts (2323)
Michigan (117)
Minnesota (256)
New Jersey (843)
New York (834)
North Carolina (739)
Northern California (1283)
Ohio (118)
Pennsylvania (737)
South America (1045)
Southern California (1096)
Texas (375)
Utah (83)
Washington State (319)
638,077 Results for "med el corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
MED-EL Presents: World Cochlear Implant Day 2023 - Over 45 years of major technological advances that enhance hearing and quality of life
MED-EL, a leader in implantable hearing solutions, celebrates together with everyone living with and benefiting from cochlear implants.
February 24, 2023
·
5 min read
Press Releases
Ahara Corporation Announces Ahara Med, an Affordable, Full-Service Medical Weight Loss Program
September 19, 2024
·
3 min read
Biotech Bay
Henry Meds Revolutionizes Weight Loss Treatment with Oral Tirzepatide Dissolvable Tablets
Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets.
May 28, 2024
·
2 min read
Pharm Country
ViroCell to present at 2024 Cell & Gene Meeting on the Med
ViroCell Biologics announces that John W. Hadden II, Chief Executive Officer, will be presenting at the annual Cell & Gene Meeting on the Med to be held April 9-11 in Rome, Italy.
April 8, 2024
·
3 min read
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
·
5 min read
·
Annalee Armstrong
Drug Development
GENFIT: Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
Ipsen and GENFIT announced full results from the pivotal Phase III ELATIVE® trial, which are being presented in a late-breaking oral session at the American Association for the Study of Liver Diseases and simultaneously published in New England Journal of Medicine.
November 13, 2023
·
16 min read
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis technology platform to address significant healthcare needs, today announced its PressureSafe™ decision support device has received U.S. Food and Drug Administration (FDA) listing or the indication of pressure injuries.
April 5, 2024
·
4 min read
Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) today announced full results from the pivotal Phase III ELATIVE® trial, which are being presented in a late-breaking oral session (Abstract #484, Monday, 13 November at 16.45 EST) at the American Association for the Study of Liver Disease (AASLD) and simultaneously published in the New England Journal of Medicine (NEJM).
November 13, 2023
·
15 min read
Genetown
Vesigen to Present at the 2024 Cell and Gene Meeting on the Med
Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that Paulash Mohsen, Chief Executive Officer, will present at the 2024 Cell and Gene Meeting on the Med on April 10th at 10:45 AM CET in Rome, Italy.
April 3, 2024
·
1 min read
1 of 63,808
Next